Graft Failure

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery

Allo HSCT for High Risk Hemoglobinopathies

Tumescence in HNC Skin Graft Reconstruction

Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

Pilot Trial of Colchicine for Graft Failure in CABG

Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy

One-year Patency Comparison Between Radial Artery and No-touch Saphenous Vein Grafts in Women Undergoing Isolated CABG

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen

RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection

Modified Second Haplo-transplantation for Graft Failure

Second Haplo-transplantation for Graft Failure

Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure

Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients

Study of the No-touch Saphenous Vein Graft

Factors for Impairment of Renal Graft Function in Intensive Care